抗氧化剂联合目标温度管理改善窒息性心脏骤停大鼠模型的心脏骤停后综合征
该研究在Sprague-Dawley大鼠7分钟未处理窒息性心脏骤停模型中,复苏后随机分为安慰剂对照、曲美他嗪(TMZ)、依达拉奉(EDA)及TMZ+EDA四组,分别在复苏后5和/或60分钟给药,100% O2通气1小时,一半动物维持常温(37.5°C)、一半低温(34.0°C)。常温下EDA较安慰剂显著提高96小时生存率、减少海马FJB阳性面积比例、降低丙二醛和8-OHDG水平;低温下TMZ、EDA及TMZ+EDA组96小时生存率均显著高于低温安慰剂组,TMZ+EDA组还显著降低胶原容积分数、FJB阳性面积比例及丙二醛、8-OHDG、H2O2水平。作者结论认为抗氧化剂联合TTM通过降低活性氧水平、减轻心肌和脑病理损伤改善心脏骤停后综合征结局。
要点
- 大鼠窒息性心脏骤停7分钟后复苏,常温(37.5°C)下依达拉奉(EDA)较安慰剂显著提高96小时生存率。
- 低温(34.0°C)下曲美他嗪(TMZ)、依达拉奉(EDA)及TMZ+EDA三组96小时生存率均显著高于低温安慰剂组。
- 低温下TMZ+EDA组胶原容积分数、海马FJB阳性面积比例及丙二醛、8-OHDG、H2O2水平均显著降低。
- 给药方案:复苏后5和/或60分钟给予葡萄糖10 mL/kg、TMZ 10 mg/kg、生理盐水10 mL/kg、EDA 3 mg/kg。
- 复苏后100% O2通气1小时,常温目标37.5°C、低温目标34.0°C。
适用人群与场景
- Sprague-Dawley大鼠,经历7分钟未处理窒息性心脏骤停后复苏成功的动物模型
处置流程与药物剂量
- 复苏后5和/或60分钟给药:葡萄糖10 mL/kg、曲美他嗪(TMZ)10 mg/kg、生理盐水10 mL/kg、依达拉奉(EDA)3 mg/kg。
- 复苏后100% O2通气1小时。
- 一半动物维持常温(37.5°C),一半维持低温(34.0°C)。
研究设计与关键结果
- 研究类型:大鼠窒息性心脏骤停模型实验;7分钟未处理窒息性心脏骤停后复苏,随机分为安慰剂对照(PBO)、曲美他嗪(TMZ)、依达拉奉(EDA)、TMZ+EDA四组。
- 常温(37.5°C)下,EDA组较常温PBO组显著提高96小时生存率、减少海马FJB阳性面积比例、降低丙二醛和8-OHDG水平。
- 低温(34.0°C)下,TMZ、EDA及TMZ+EDA组96小时生存率均显著高于低温PBO组。
- 低温下TMZ+EDA组胶原容积分数和海马FJB阳性面积比例显著降低,丙二醛、8-OHDG和H2O2水平显著降低。
证据类型、等级与局限
- 证据类型:动物实验(大鼠模型)。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出临床推荐;作者结论认为抗氧化剂联合TTM通过降低活性氧水平、减轻心肌和脑病理损伤改善心脏骤停后综合征结局,该结论来自大鼠窒息性心脏骤停模型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Postcardiac arrest syndrome (PCAS) is a complex pathophysiological processes occurring after return of spontaneous circulation (ROSC) following cardiac arrest (CA), which may lead to multiple organ failure and death. The clinical efficacy of conventional therapies such as oxygen therapy and targeted temperature management (TTM) are remaining limited. Given the central role of oxidative stress in the progression of PCAS, we investigated the effect of combining antioxidants with TTM in an asphyxial CA rat model. Methods and Results: After 7 min of untreated asphyxial CA in Sprague-Dawley rats, animals were randomized into four groups: 1) placebo control (PBO); 2) trimetazidine (TMZ); 3) edaravone (EDA); 4) TMZ + EDA. Glucose (10 mL/kg), TMZ (10 mg/kg), saline (10 mL/kg), and EDA (3 mg/kg) were administered at 5 and/or 60 min after resuscitation. Animals were ventilated with 100% O 2 for 1 h after ROSC. Half of the animals were maintained at normothermia (37.5°C) and half at hypothermia (34.0°C). Under normothermia, the administration of EDA significantly improved 96-h survival rates, reduced the proportion of FJB-positive areas in the hippocampus and decreased malondialdehyde and 8-OHDG levels compared to normothermia PBO. Under hypothermia, the 96-h survival rates were markedly higher in TMZ, EDA, and TMZ + EDA groups than in hypothermia PBO. Furthermore, collagen volume fraction and the proportion of FJB-positive areas were markedly reduced, while malondialdehyde, 8-OHDG, and H 2 O 2 were significantly decreased in TMZ + EDA group. Conclusions : Combining antioxidants with TTM alleviates PCAS and improves outcomes by reducing reactive oxygen species levels and mitigating myocardial and cerebral pathological injury.
参考来源
- Li J, Liu X, Wang J, et al. COMBINATION OF ANTIOXIDANTS AND TARGETED TEMPERATURE MANAGEMENT AMELIORATES POSTCARDIAC ARREST SYNDROME IN A RAT MODEL OF ASPHYXIAL CARDIAC ARREST. Shock. 2025. PMID: 40333436. doi:10.1097/SHK.0000000000002616
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。